Activation of the complement system by nanoparticles and strategies for complement inhibition

被引:1
|
作者
Haroon, Hajira B. [1 ,2 ]
Dhillon, Elisha [1 ]
Farhangrazi, Z. Shadi [3 ,4 ]
Trohopoulos, Panagiotis N. [5 ]
Simberg, Dmitri [6 ,7 ]
Moghimi, S. Moein [1 ,2 ,7 ]
机构
[1] Newcastle Univ, Sch Pharm, Newcastle Upon Tyne NE1 7RU, England
[2] Newcastle Univ, Translat & Clin Res Inst, Fac Hlth & Med Sci, Newcastle Upon Tyne NE2 4HH, England
[3] SM Discovery Grp Inc, Denver, CO USA
[4] SM Discovery Grp Ltd, Durham, England
[5] CosmoPHOS Ltd, Thessaloniki, Greece
[6] Univ Colorado, Anschutz Med Ctr, Skaggs Sch Pharm, Dept Pharmaceut Sci,Translat Bionanosci Lab, Aurora, CO USA
[7] Univ Colorado, Colorado Ctr Nanomed & Nanosafety, Anschutz Med Ctr, Aurora, CO USA
关键词
Complement; Complement inhibitors; Complement regulators; Complement receptors; Complosome; Nanoparticles; Opsonisation; C3; PATHWAY; BINDING; COMPONENT; RESPONSES; ANAPHYLATOXIN; ANTIBODIES; PROTEINS; SURFACES;
D O I
10.1016/j.ejpb.2023.11.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The complement system is a multicomponent and multifunctional arm of the innate immune system. Complement contributes to non-specific host defence and maintains homeostasis through multifaceted processes and pathways, including crosstalk with the adaptive immune system, the contact (coagulation) and the kinin systems, and alarmin high-mobility group box 1. Complement is also present intracellularly, orchestrating a wide range of housekeeping and physiological processes in both immune and nonimmune cells, thus showing its more so-phisticated roles beyond innate immunity, but its roles are still controversial. Particulate drug carriers and nanopharmaceuticals typically present architectures and surface patterns that trigger complement system in different ways, resulting in both beneficial and adverse responses depending on the extent of complement activation and regulation as well as pathophysiological circumstances. Here we consider the role of complement system and complement regulations in host defence and evaluate the mechanisms by which nanoparticles trigger and modulate complement responses. Effective strategies for the prevention of nanoparticle-mediated complement activation are introduced and discussed.
引用
收藏
页码:227 / 240
页数:14
相关论文
共 50 条
  • [1] Inhibition of complement activation
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (01) : 13 - 13
  • [2] Strategies of therapeutic complement inhibition
    Mollnes, TE
    Kirschfink, M
    MOLECULAR IMMUNOLOGY, 2006, 43 (1-2) : 107 - 121
  • [3] Targeted nanoparticles and complement activation
    Macor, Paolo
    Capolla, S.
    Colombo, F.
    De Maso, L.
    Durigutto, P.
    Tedesco, F.
    Macor, P.
    MOLECULAR IMMUNOLOGY, 2017, 89 : 204 - 204
  • [4] Ambivalent effect of immunoglobulins on the complement system: Activation versus inhibition
    Basta, Milan
    MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4073 - 4079
  • [5] Inhibition of complement activation in cardiac surgery
    Sellke, FW
    Boodhwani, M
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 131 (02): : 266 - 267
  • [6] INHIBITION OF COMPLEMENT ACTIVATION BY INTRAVENOUS IMMUNOGLOBULINS
    QI, M
    SCHIFFERLI, JA
    ARTHRITIS AND RHEUMATISM, 1995, 38 (01): : 146 - 146
  • [7] INHIBITION OF COMPLEMENT ACTIVATION BY IVIG ADMINISTRATION
    Machimoto, Takafumi
    Guerra, Giselle
    Colona, Jane
    Ruiz, Phillip
    Meier-Kriesche, Herwig-Ulf
    Scornik, Juan
    HUMAN IMMUNOLOGY, 2009, 70 : S75 - S75
  • [8] Complement Activation and Inhibition inWound Healing
    Cazander, Gwendolyn
    Jukema, Gerrolt N.
    Nibbering, Peter H.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [9] Complement activation and inhibition: a delicate balance
    Sjoberg, A. P.
    Trouw, L. A.
    Blom, A. M.
    TRENDS IN IMMUNOLOGY, 2009, 30 (02) : 83 - 90
  • [10] Complement activation turnover on surfaces of nanoparticles
    Moghimi, S. M.
    Simberg, D.
    NANO TODAY, 2017, 15 : 8 - 10